{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:39:29Z","timestamp":1763746769829,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.jns.2009.01.019","type":"journal-article","created":{"date-parts":[[2009,2,22]],"date-time":"2009-02-22T03:17:22Z","timestamp":1235272642000},"page":"109-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prulifloxacin as a trigger of myasthenia gravis"],"prefix":"10.1016","volume":"280","author":[{"given":"Marco","family":"Rossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaia","family":"Lusini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Biasella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Mazzocchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2009.01.019_bib1","unstructured":"http:\/\/www.myasthenia.org\/docs\/MGFA_MedicationsandMG.pdf. Accessed 16 October 2008."},{"issue":"8590","key":"10.1016\/j.jns.2009.01.019_bib2","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(88)91627-3","article-title":"Possible exacerbation of myasthenia gravis by ciprofloxacin","volume":"1","author":"Moore","year":"1988","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jns.2009.01.019_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/106002809002400219","article-title":"Exacerbation of myasthenia gravis by norfloxacin","volume":"24","author":"Rauser","year":"1990","journal-title":"DICP"},{"issue":"6755","key":"10.1016\/j.jns.2009.01.019_bib4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/bmj.301.6755.818-a","article-title":"Ciprofloxacin and myasthenia gravis","volume":"301","author":"Mumford","year":"1990","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.jns.2009.01.019_bib5","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/BF00874123","article-title":"Probable exacerbation of myasthenia gravis by ofloxacin","volume":"240","author":"Azevedo","year":"1993","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.jns.2009.01.019_bib6","first-page":"286","article-title":"[Exacerbation of myasthenia gravis by pefloxacin]","volume":"151","author":"Vial","year":"1995","journal-title":"Rev Neurol (Paris)"},{"issue":"6","key":"10.1016\/j.jns.2009.01.019_bib7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1600-0404.1996.tb00055.x","article-title":"Myasthenia gravis and ciprofloxacin","volume":"94","author":"Roquer","year":"1996","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"10.1016\/j.jns.2009.01.019_bib8","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/emj.2006.038091","article-title":"Levofloxacin induced myasthenia crisis","volume":"23","author":"Gunduz","year":"2006","journal-title":"Emerg Med J"},{"issue":"2","key":"10.1016\/j.jns.2009.01.019_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0006-8993(95)01349-0","article-title":"Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission","volume":"18;712","author":"Sieb","year":"1996","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.jns.2009.01.019_bib10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1212\/WNL.50.3.804","article-title":"Fluoroquinolone antibiotics block neuromuscular transmission","volume":"50","author":"Sieb","year":"1998","journal-title":"Neurology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X09000471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X09000471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:38:54Z","timestamp":1758382734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X09000471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":10,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0022510X09000471"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2009.01.019","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prulifloxacin as a trigger of myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2009.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}